Table 4.

Use the expression levels of circBRIP1, CEA, SCC, Cyfra21-1 to distinguish NSCLC patients from BPD

	SEN	SPN	ACCU	PPV	NPV
circBRIP1	0.56 (56/100)	0.88 (34/40)	0.65 (91/140)	0.92 (56/61)	0.44 (35/79)
CEA	0.39 (39/100)	0.70 (28/40)	0.48 (67/140)	0.76 (39/51)	0.31 (28/89)
SCC	0.28 (28/100)	0.55 (22/40)	0.36 (50/140)	0.61 (28/46)	0.23 (22/94)
Cyfra21-1	0.41 (41/100)	0.2 (8/40)	0.35 (49/140)	0.56 (41/73)	0.12 (8/67)
circBRIP1 + CEA	0.76 (76/100)	0.63 (25/40)	0.72 (101/140)	0.72 (76/106)	0.71 (25/35)
circBRIP1 + SCC	0.70 (70/100)	0.45 (18/40)	0.63 (88/140)	0.63 (70/112)	0.64 (18/28)
circBRIP1 + Cyfra21-1	0.73 (73/100)	0.20 (8/40)	0.58 (81/140)	0.59 (73/124)	0.50 (8/16)
circBRIP1 + CEA + SCC	0.80 (80/100)	0.30 (12/40)	0.66 (92/140)	0.67 (80/120)	0.60(12/20)
circBRIP1 + CEA + Cyfra21-1	0.81 (81/100)	0.23 (9/40)	0.64 (90/140)	0.72 (81/112)	0.32(9/28)
circBRIP1 + SCC + Cyfra21-1	0.77 (77/100)	0.15 (6/40)	0.59 (83/140)	0.69 (77/111)	0.21(6/29)
circBRIP1 + CEA + SCC + Cyfra21-1	0.83 (83/100)	0.15 (6/40)	0.64 (89/140)	0.71 (83/117)	0.26(6/23)